Solara Active Pharma Sciences Limited

NSE:SOLARA.NS

502.5 (INR) • At close May 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q22017 Q1
Omzet 3,003.13,469.53,634.92,626.42,487.34,252.43,523.13,806.23,947.53,383.73,300.73,230.31,003.44,016.14,055.74,030.64,266.93,975.63,484.22,426.63,436.83,511.33,301.73,207.133,562.33,423.33,028.13,042398.182,585.22
Kosten van de omzet 1,348.62,499.42,816.61,599.83,041.22,375.31,919.91,924.32,113.91,893.91,956.12,780.6541.61,871.11,784.62,580.51,876.91,741.61,496.81,7121,4821,696.21,517.12,433.331,755.51,760.61,518.41,550241.471,311.17
Brutowinst 1,654.5970.1818.31,026.6-553.91,877.11,603.21,881.91,833.61,489.81,344.6449.7461.82,1452,271.11,450.12,3902,2341,987.4714.61,954.81,815.11,784.6773.81,806.81,662.71,509.71,492156.711,274.05
Brutowinstmarge 0.5510.280.2250.391-0.2230.4410.4550.4940.4640.440.4070.1390.460.5340.560.360.560.5620.570.2940.5690.5170.5410.2410.5070.4860.4990.490.3940.493
Onderzoek- en ontwikkelingskosten 0001,010108110100103959580119135143141140.11381110225.71341100229.310411102700
Algemene en administratieve kosten 0000000680.7000571.2000609.1000557.3000528.5000000
Verkoop- en marketingkosten 00000008.60003.80003.100015.600022.8000000
Verkoop-, algemene en administratieve kosten 331.4610.4649.8736.81,214.6749.6611.5689.3704.1557.6600.7575640624604.4612.2598.8580.1545572.9514.3506.3486.3551.3487.4460.5427.51,03500
Overige kosten 1,323.105.617-1,318.111.820.446.871.737.269.8-63.247.333.159.1-105.382.961.245.8-4660.849.543.617.0738.813.94.80-19.7122.61
Bedrijfskosten 1,654.5610.4649.81,181.51,322.61,762.91,671.11,658.71,663.41,500.41,500.4441.81,714.61,710.21,633.7701.31,610.51,533.81,411.7407.21,416.61,369.91,376.7229.221,399.21,375.41,239.81,28573.381,070.96
Bedrijfsresultaat 331.4359.7168.5-137.9-1,876.5126-67.9270241.926.6-155.8-142.9-1,252.8434.8637.4748.8779.5700.2575.7307.4538.2445.2407.9544.58407.6287.3269.925483.33203.09
Bedrijfsresultaat ratio 0.110.1040.046-0.053-0.7540.03-0.0190.0710.0610.008-0.047-0.044-1.2490.1080.1570.1860.1830.1760.1650.1270.1570.1270.1240.170.1140.0840.0890.0830.2090.079
Totaal overige inkomsten en kosten netto -250.5-279.6-303.1-1,255.7-2,199.5-284.8-225.7-172.9-164.7-182.4-155.2-167.1-146.1-138-136.3-205.6-121.6-132.5-152.5-121.4-124.9-153.4-142.9-277.85-186.6-185.5-177.4-346122.64-15.72
Inkomen voor belasting 80.980.1-134.6-1,666.6-2,753.4-170.6-293.650.45.5-193-311-310-1,398.9296.8501.1566.2657.9567.7423.2179413.3291.8265261.53221101.892.584205.97187.37
Inkomen voor belasting ratio 0.0270.023-0.037-0.635-1.107-0.04-0.0830.0130.001-0.057-0.094-0.096-1.3940.0740.1240.140.1540.1430.1210.0740.120.0830.080.0820.0620.030.0310.0280.5170.072
Belastingkosten 000887.9259.641-102.512.8-1.2-93.2-144.5-221.947.132.858.90.10.10.80.50.960.5343.4-0.438.96.371.7213.7729.2
Nettowinst 80.980.1-134.6-2,553.4-2,753.4-171.6-195.537.64.5-99.6-164.318.8-1,398.7297.1501.3566.5658566.7422.8178.2413.6289.1265.2263.27220.985.325.663202.04158.26
Nettowinstmarge 0.0270.023-0.037-0.972-1.107-0.04-0.0550.010.001-0.029-0.050.006-1.3940.0740.1240.1410.1540.1430.1210.0730.120.0820.080.0820.0620.0250.0080.0210.5070.061
WPA (Winst Per Aandeel) 2.031.67-3.5-65.37-76.49-4.77-5.431.050.13-2.77-4.570.53-38.938.2713.9515.918.4719.2115.756.041611.2110.298.928.963.460.232.556.8514.13
Verwaterde WPA 2.031.67-3.5-65.37-76.49-4.77-5.431.050.13-2.77-4.560.52-38.938.2213.8815.917.2917.2514.746.0415.2411.1610.228.928.953.460.232.556.8514.13
EBITDA 591.7616.3424.8-1,107.2-2,240.11335.9211.6534.5521.7312.9195.3182.9-936.3750.9967.51,088.91,136.31,037.4883.8622.1837.4729.7680.4619.45658.5494.9465.8333.1888.48395.61
EBITDA ratio 0.1970.1780.117-0.422-0.9010.0790.060.140.1320.0920.0590.057-0.9330.1870.2390.270.2660.2610.2540.2560.2440.2080.2060.1930.1850.1450.1540.110.2220.153